Equivalent Dynamic Human Brain NK1‐Receptor Occupancy Following Single‐Dose i.v. Fosaprepitant vs. Oral Aprepitant as Assessed by PET Imaging

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-6535|92|2|243-250

ISSN： 0009-9236

Source： CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.92, Iss.2, 2012-08, pp. : 243-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The NK1 receptor antagonist aprepitant attenuates NK1 agonist‐induced scratching behaviour in the gerbil after intra‐dermal, topical or oral administration

By  

EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol. 24, Iss. 4, 2015-04 ,pp. : 312-314

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of hepatic impairment on lenvatinib pharmacokinetics following single‐dose oral administration

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 3, 2015-03 ,pp. : 317-327

John Wiley & Sons Inc

Access to resources Recommend Favorite

Quantitative imaging of protein targets in the human brain with PET

By Gunn Roger N   Slifstein Mark   Searle Graham E   Price Julie C  

Physics in Medicine and Biology, Vol. 60, Iss. 22, 2015-11 ,pp. : R363-R411

IOP Publishing

Access to resources Recommend Favorite

A Phase 1, Randomized Ascending Single‐Dose Study of Antagonist Anti‐Human CD40 ASKP1240 in Healthy Subjects

By  

AMERICAN JOURNAL OF TRANSPLANTATION, Vol. 13, Iss. 4, 2013-04 ,pp. : 1040-1046

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 3, 2018-03 ,pp. : 602-603

John Wiley & Sons Inc

Access to resources Recommend Favorite